Week 1 of starting Zepbound (initial 2.5 mg dose) your gut is meeting tirzepatide for the first time
Peer review Peer review information Communications Chemistry thanks Venkatnarayan Ramanathan and the other, anonymous, reviewer for their contribution to the peer review of this work
Liraglutide 1.8mg (Victoza) has demonstrated cardiovascular safety in patients with type 2 diabetes in clinical trials, though this evidence may not directly apply to Saxenda's use for weight management
Read our story: To view or add a comment, sign in The Q1 2026 issue of Global Health & Pharma Magazine is now live
Weight Loss and Blood Clot Risk Doctors know obesity is a key reason behind higher risks of blood clots
These medications dramatically reduce hunger, but they dont replace the fundamentals: adequate protein, hydration, fiber, movement and strength training